Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus

OBJECTIVE: To evaluate the relationship between the time elapsed from the administration of ampicillin prophylaxis to delivery and its efficacy in interrupting intrapartum transmission of group B streptococcus. METHODS: During the 12-month study period, all women who came to the Virgen de las Nieves Hospital (Granada, Spain) for delivery were screened for group B streptococcus vaginal carriage by a pigment-detection culture-based procedure. Colonized women were treated with ampicillin (2 g intravenously), and the interval between ampicillin administration and delivery was recorded. Newborns from colonized mothers also were screened to detect group B streptococcus colonization. RESULTS: During the study period, 4525 women were admitted to the hospital for delivery and screened for group B streptococcus vaginal colonization. Group B streptococcus was detected in 543 women (12%), of whom 454 gave birth vaginally to 454 liveborn infants. Intrapartum ampicillin was given to 201 of these 454 women (44%), and 10% of the newborns from mothers who received intrapartum ampicillin prophylaxis were colonized by group B streptococcus. The relationship between timing of ampicillin administration and rate of neonatal group B streptococcal transmission was as follows: less than 1 hour before delivery, 46%; 1-2 hours, 29%; 2-4 hours, 2.9%; and more than 4 hours, 1.2%. Among the 253 mothers who received no intrapartum prophylaxis, colonization was found in 120 of their newborns (47%). CONCLUSION: When the time between the start of ampicillin prophylaxis and delivery is at least 2 hours, vertical transmission of group B streptococcus is minimized.

This article has been cited by other articles:

				E. L. Barber, G. Zhao, I. A. Buhimschi, and J. L. Illuzzi Duration of Intrapartum Prophylaxis and Concentration of Penicillin G in Fetal Serum at Delivery Obstet. Gynecol., August 1, 2008; 112(2): 265 - 270. [Abstract] [Full Text] [PDF]

				J. L. Illuzzi and M. B. Bracken Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: a systematic review. Obstet. Gynecol., November 1, 2006; 108(5): 1254 - 1265. [Abstract] [Full Text] [PDF]

				P. F. Tumbaga and A. G.S. Philip Perinatal Group B Streptococcal Infections and the New Guidelines: An Update NeoReviews, October 1, 2006; 7(10): e524 - e530. [Full Text] [PDF]

				L. E. Riley and S. Yawetz Case records of the Massachusetts General Hospital. Case 32-2005. A 34-year-old HIV-positive woman who desired to become pregnant. N. Engl. J. Med., October 20, 2005; 353(16): 1725 - 1732. [Full Text] [PDF]

				P. F. Tumbaga and A. G. S. Philip Perinatal Group B Streptococcal Infections: Past, Present, and Future NeoReviews, March 1, 2003; 4(3): e65 - 72. [Full Text] [PDF]

				C. A. Haberland, W. E. Benitz, G. D. Sanders, J. B. Pietzsch, S. Yamada, L. Nguyen, and A. M. Garber Perinatal Screening for Group B Streptococci: Cost-Benefit Analysis of Rapid Polymerase Chain Reaction Pediatrics, September 1, 2002; 110(3): 471 - 480. [Abstract] [Full Text] [PDF]

				S. Oddie and N. D Embleton Risk factors for early onset neonatal group B streptococcal sepsis: case-control study BMJ, August 10, 2002; 325(7359): 308 - 308. [Abstract] [Full Text] [PDF]

				G. J. Escobar, D.-k. Li, M. A. Armstrong, M. N. Gardner, B. F. Folck, J. E. Verdi, B. Xiong, R. Bergen, and for the Neonatal Infection Study Group Neonatal Sepsis Workups in Infants >= 2000 Grams at Birth: A Population-Based Study Pediatrics, August 1, 2000; 106(2): 256 - 263. [Abstract] [Full Text]

				W. David Hager, A. Schuchat, R. Gibbs, R. Sweet, P. Mead, and J. W. Larsen PREVENTION OF PERINATAL GROUP B STREPTOCOCCAL INFECTION: CURRENT CONTROVERSIES Obstet. Gynecol., July 1, 2000; 96(1): 141 - 145. [Abstract] [Full Text] [PDF]

				B. S. BROZANSKI, J. G. JONES, M. A. KROHN, and R. L. SWEET Effect of a Screening-based Prevention Policy on Prevalence of Early-Onset Group B Streptococcal Sepsis Obstet. Gynecol., April 1, 2000; 95(4): 496 - 501. [Abstract] [Full Text] [PDF]

				A. Schuchat, S. S. Zywicki, M. J. Dinsmoor, B. Mercer, J. Romaguera, M. J. O'Sullivan, D. Patel, M. T. Peters, B. Stoll, and O. S. Levine Risk Factors and Opportunities for Prevention of Early-onset Neonatal Sepsis: A Multicenter Case-Control Study Pediatrics, January 1, 2000; 105(1): 21 - 26. [Abstract] [Full Text] [PDF]

				W. E. Benitz, J. B. Gould, and M. L. Druzin Antimicrobial Prevention of Early-onset Group B Streptococcal Sepsis: Estimates of Risk Reduction Based on a Critical Literature Review Pediatrics, June 1, 1999; 103(6): 78e - 78. [Abstract] [Full Text]